Acne and rosacea therapies see the light

Acne and rosacea are associated with substantial psychosocial morbidity that profoundly affects the quality of life. Our patients' perspective on how well they respond to treatment is crucial in orchestrating their therapeutic regimen (determined by patient-reported outcome measures).1 Despite their different pathophysiology, both disorders are treated with similar topical and oral agents. In this issue of the Journal of the American Academy of Dermatology, 4 articles are devoted to treat acne and rosacea.